申请人:CONCERT PHARMACEUTICALS INC
公开号:WO2014100431A1
公开(公告)日:2014-06-26
This invention relates to novel ALK inhibitors of Formula I: as defined in the specification, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering ALK inhibitors.